4K^® score test in the time of COVID-19 quarantine - implications for timely diagnosis of high-risk prostate cancer

Friedman Boris¹,Neuberger Ami², Ephrat Omer¹, Manaster Yoav³, Freifeld Yuval¹, Dekel Yoram¹

1- Urology Department, Carmel Lady Davis medical center, Haifa, Israel

2 - Infectious Disease Department, Rambam Health care Campus, Haifa, Israel

3 - Progenetics company LTD

Friedman Boris – friedmanboris173@gmail.com

Neuberger Ami – a_neuberger@rambam.health.gov.il

Ephrat Omer – omerephratmed@gmail.com

Manaster Yoav – yoav@progenetics.co.il

Freifeld Yuval – yuvalfr@clalit.org.il

Dekel Yoram - yoramd@clalit.org.il